"Searchlight is a unique company, in that what drives our thinking from a business development and commercial perspective, is that we do not think about healthcare…
In Conversation
"In the healthcare market, Poland is safe to invest, no matter the regulations."
"Canada could find advantage by positioning itself as a country of excellence for smaller studies or more complex studies requiring innovative designs, the type ethica CRO…
"Currently CMED's main objective is to move forward with the regulatory apparatus for the new challenges and promote transparency."
"Switzerland is home to a significantly high amount of regional headquarters of global pharma and biotech companies. Chances are that if they are our clients in…
"In Austria, we will generate higher revenues than in 2016. It has hence been a good year for us"
"Our Canadian affiliate has also proven a pronounced capacity in pioneering when it comes to internal initiatives and positioned itself as an exporter of best practices."
"There is a strong community spirit across the Balkans, and it is one of those countries where people take care of people; the state is not…
"In terms of access to medicine in Lithuania, only 22 percent of all the innovative drugs that were centrally approved by the EMA from 2006 to…
"A drug policy that enhances access to healthcare, encourages innovation and enables ease of doing business can be the only sustainable way to address the unique…
Jonathan Koch, group president R&D Laboratories at Swiss-based CRO, Covance, explains how the integration process with LabCorb has progressed over the last two years, Covance’s embrace…
"In Brazil, BMS displays a profile and a vision that is perfectly aligned with the global level."
